Fund Overview
Fund
ICICI Prudential Nifty Pharma Index Fund
Underlying Index: Nifty PharmaISIN: INF109KC11M9
20.1917.50% (1Y)
End of Day NAV as on Oct 12, 2026
Fundamentals
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 20 Companies |
| Market Cap Focus | Multi / Flexi Cap |
| Std Deviation (1 yr) | 0.85% |
| P/E | 52.99 |
| P/B | 8.08 |
| Div Yield | 0.56% |
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 20 |
| Market Cap Focus | Multi / Flexi Cap |
| P/E | 52.99 |
| P/B | 8.08 |
| Div Yield | 0.56% |
| Std Deviation (1 yr) | 0.85% |
Fund Parameters
| AUM (Cr) | 157 |
| Base Expense Ratio | 0.32% |
| Tracking Error | 0.06% |
| All-In-Cost | 0.38% |
| Inception Date | 14 Dec 2022 |
| Scheme Plan - Option - Type | Direct Plan - Growth - Open ended scheme |
Native Score
| AUM (Cr) | 157 |
| Base Expense Ratio | 0.32% |
| Tracking Error | 0.06% |
| All-In-Cost | 0.38% |
| Inception Date | 14 Dec 2022 |
| Scheme Plan - Option - Type | Direct Plan - Growth - Open ended scheme |
| Native Score |
Similar Exchange Traded Funds (ETFs)
| Fund Name | ||||||||
|---|---|---|---|---|---|---|---|---|
| 26.78 | 1,761 | 0.18% | 0.02% | 12 | 0.11% | 0.31% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | 1M ADTO (Cr) | 1M Avg NAV Gap | All-In-Cost | Score |
|---|---|---|---|---|---|---|---|---|
| 26.78 | 1,761 | 0.18% | 0.02% | 12 | 0.11% | 0.31% |
Similar Index Funds
No similar index funds available for this index
Sectoral Allocation
Total
100%
allocation
- Healthcare99.9%
- Miscellaneous1.1%
- Healthcare99.9%
- Miscellaneous1.1%
Fund Holdings
| Name | Weight |
|---|
| Sun Pharmaceutical Industries Ltd. | 20.8% |
| Divi's Laboratories Ltd. | 11.9% |
| Cipla Ltd. | 7.8% |
| Laurus Labs Ltd. | 7.4% |
| Torrent Pharmaceuticals Ltd. | 7.3% |
| Dr. Reddy's Laboratories Ltd. | 7.0% |
| Lupin Ltd. | 5.2% |
| Aurobindo Pharma Ltd. | 4.7% |
| Glenmark Pharmaceuticals Ltd. | 3.7% |
| Alkem Laboratories Ltd. | 3.1% |
| Biocon Ltd. | 2.9% |
| Zydus Lifesciences Ltd. | 2.9% |
| Ipca Laboratories Ltd. | 2.7% |
| Mankind Pharma Ltd. | 2.7% |
| Gland Pharma Ltd. | 2.3% |
| Sai Life Sciences Ltd. | 2.0% |
| Wockhardt Ltd. | 1.5% |
| Ajanta Pharma Ltd. | 1.5% |
| Piramal Pharma Ltd. | 1.3% |
| Abbott India Ltd. | 1.3% |
| Tri-Party Repo (TREPS) | 1.1% |
| Net Current Asset | -1.0% |
NameWeight
Sun Pharmaceutical Industries Ltd.20.8%
Divi's Laboratories Ltd.11.9%
Cipla Ltd.7.8%
Laurus Labs Ltd.7.4%
Torrent Pharmaceuticals Ltd.7.3%
Dr. Reddy's Laboratories Ltd.7.0%
Lupin Ltd.5.2%
Aurobindo Pharma Ltd.4.7%
Glenmark Pharmaceuticals Ltd.3.7%
Alkem Laboratories Ltd.3.1%
Biocon Ltd.2.9%
Zydus Lifesciences Ltd.2.9%
Ipca Laboratories Ltd.2.7%
Mankind Pharma Ltd.2.7%
Gland Pharma Ltd.2.3%
Sai Life Sciences Ltd.2.0%
Wockhardt Ltd.1.5%
Ajanta Pharma Ltd.1.5%
Piramal Pharma Ltd.1.3%
Abbott India Ltd.1.3%
Tri-Party Repo (TREPS)1.1%
Net Current Asset-1.0%
Holdings Concentration
Total covered: 101%
Top 1–5
5 holdings
55.2%
55%
share
Top 6–10
5 holdings
23.7%
23%
share
Top 11–20
10 holdings
21.1%
21%
share
Beyond 20
1 holding
1.1%
1%
share
Market Cap Classification
Total
100%
allocation
- Large Cap47.8%
- Mid Cap45.0%
- Small Cap7.1%
- Large Cap47.8%
- Mid Cap45.0%
- Small Cap7.1%
Advanced Ratios
| Alpha | -0.01 |
| Beta | 1.00 |
| Sharpe Ratio | 0.09 |
| Sortino Ratio | 0.17 |
| Treynor Ratio | 0.08 |
| Information Ratio | -0.12 |
| Upside Capture | 98.25% |
| Downside Capture | 100.11% |
Index Methodology
| Factor Basis | Sector/Theme |
| What universe selected from? | Nifty 500 |
| Weightage? | Free-Float Market Cap Weighting; Max Weight per stock = 33% |
| Stocks Included | Max 20 stocks. Top 20 stocks from the Indian Pharma & Biotech sector are selected. |
| Exclusions | Constituents moving out of the Nifty 500 and currently part of the Nifty Pharma Index are excluded; |
| Factor Basis | Sector/Theme |
| Universe | Nifty 500 |
| Weightage | Free-Float Market Cap Weighting; Max Weight per stock = 33% |
| Stocks Included | Max 20 stocks. Top 20 stocks from the Indian Pharma & Biotech sector are selected. |
| Exclusions | Constituents moving out of the Nifty 500 and currently part of the Nifty Pharma Index are excluded; |
Fund • Last updated: 13/10/2026